TipRanks
TYK Medicines, Inc. Class H (HK:2410)
:2410
Hong Kong Market
2410
TYK Medicines, Inc. Class H
RESEARCH TOOLSreports
Want to see HK:2410 full AI Analyst Report?

TYK Medicines, Inc. Class H (2410) Financial Statements

2 Followers

TYK Medicines, Inc. Class H Financial Overview

TYK Medicines, Inc. Class H's market cap is currently HK$1.24B. The company's EPS TTM is HK$-0.61; its P/E ratio is -3.56; TYK Medicines, Inc. Class H is scheduled to report earnings on August 17, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue¥ 0.00¥ 107.00K¥ 0.00¥ 44.24M
Gross Profit¥ -24.37M¥ 14.00K¥ -27.66M¥ 20.04M
Operating Income¥ -314.19M¥ -316.80M¥ -286.24M¥ -234.79M
EBITDA¥ -289.82M¥ -346.03M¥ -346.80M¥ -292.22M
Net Income¥ -292.01M¥ -386.95M¥ -382.43M¥ -310.99M
Balance Sheet
Cash & Short-Term Investments¥ 367.44M¥ 435.46M¥ 192.83M¥ 243.49M
Total Assets¥ 780.07M¥ 915.69M¥ 573.14M¥ 558.36M
Total Debt¥ 152.81M¥ 176.85M¥ 1.33B¥ 82.33M
Net Debt¥ -214.63M¥ -258.62M¥ 1.14B¥ -8.44M
Total Liabilities¥ 449.15M¥ 443.13M¥ 1.45B¥ 1.06B
Stockholders' Equity¥ 286.79M¥ 469.09M¥ -973.82M¥ -505.94M
Cash Flow
Free Cash Flow¥ -255.18M¥ -381.87M¥ -278.20M¥ -308.23M
Operating Cash Flow¥ -215.77M¥ -308.25M¥ -200.94M¥ -220.05M
Investing Cash Flow¥ 35.95M¥ -135.86M¥ 73.01M¥ -158.16M
Financing Cash Flow¥ 126.38M¥ 632.08M¥ 224.00M¥ 351.14M
Currency in CNY

TYK Medicines, Inc. Class H Earnings and Revenue History

Income Statement >

TYK Medicines, Inc. Class H Debt to Assets

Balance Sheet >

TYK Medicines, Inc. Class H Cash Flow

Cash Flow >

TYK Medicines, Inc. Class H Forecast EPS vs Actual EPS

Earnings >